AVS Nutrition sold to Singaporean Healthcare group, Veritas

26.9.2018

AVS Nutrition Ltd, a leading contract manufacturer of food, vitamin, supplement and complementary medicine, was sold to Verita Healthcare Group Ltd, a Singapore-based group providing preventative healthcare solutions.

AVS provides a range of services to brands looking for an alternate supplier or to those looking for new concepts; from sourcing, supplying, packaging and contract manufacturing to development of customised products and innovative formulations. The business is based in Ballina, NSW.

The shareholders of AVS were seeking a partner to help grow, as well as realize some liquidity for their investment in the business.

Clairfield introduced AVS to Verita Healthcare Group. Verita was seeking to expand its presence in Australia, complementing its existing presence. Clairfield represented AVS throughout the transaction process, including introducing the investor, managing due diligence advisors, and working closely with both the buyer and seller to ensure a transaction structure which created alignment for all parties.

InterFinancial  acted as exclusive financial advisor to AVS Nutrition.

Transactions of this nature can be challenging and time consuming. Clairfield Australia (InterFinancial) connected us with an interested party, managed the process of negotiations and due diligence, and ultimately we’ve ended up in a position where all parties have achieved a really positive outcome. Having had their guidance and follow up in the background along the entire way has been invaluable to us, whilst we’ve continued to run our business from day to day.
— Mikko Helle, CEO

Deal team:

Mark Steinhardt
Anthony Vago
Andrew Wheeler

29.5.2026

Sector dashboards May 2026

Our monthly sector dashboards are out! Our dashboards look at the valuation multiples across seven key sectors, each made up of a number of subsectors. The data takes into account the sale prices of similar companies based on; products, end markets, services, assets classes or other characteristics. The publications include all companies listed on the […]

Read more
28.5.2026

InterFinancial advises Commit Works on sale to Datamine

Commit Works is a Brisbane-based software company serving the mining and metals industry. Its CiteOps platform digitises shift-level planning, resource allocation, task coordination and production tracking, connecting the short-term plan to what actually happens on shift across underground coal, open cut, underground hardrock and smelter operations globally. Datamine is the world’s leading provider of technology […]

Read more
29.4.2026

Sector dashboards April 2026

Our monthly sector dashboards are out! Our dashboards look at the valuation multiples across seven key sectors, each made up of a number of subsectors. The data takes into account the sale prices of similar companies based on; products, end markets, services, assets classes or other characteristics. The publications include all companies listed on the […]

Read more
29.4.2026

From technical capability to economic inevitability: Why Clean Energy companies fail to scale?

Working with organisations attempting to commercialise clean energy technologies, I have observed a pattern persistent enough to warrant explicit articulation. Across hydrogen, electrification, storage, biogas, low-carbon fuels, and industrial heat, companies with credible technology, capable teams, and supportive boards still fail to compound enterprise value. Not because the technology disappoints, and not because the market […]

Read more
31.3.2026

Sector dashboards March 2026

Our monthly sector dashboards are out! Our dashboards look at the valuation multiples across seven key sectors, each made up of a number of subsectors. The data takes into account the sale prices of similar companies based on; products, end markets, services, assets classes or other characteristics. The publications include all companies listed on the […]

Read more
31.3.2026

Not every healthcare deal is a sale: rethinking what M&A can look like

When healthcare business owners come to us thinking about a transaction, the conversation almost always starts in the same place. What is the business worth, and what does a sale process look like? Those are the right questions. But they’re not always the only ones that matter. Embedded in both is an assumption; that the […]

Read more
27.2.2026

Sector dashboards February 2026

Our monthly sector dashboards are out! Our dashboards look at the valuation multiples across seven key sectors, each made up of a number of subsectors. The data takes into account the sale prices of similar companies based on; products, end markets, services, assets classes or other characteristics. The publications include all companies listed on the […]

Read more
27.2.2026

On the floor at EvokeAg 2026: Luke Harwood’s reflections on Australian Agtech

EvokeAg 2026 drew over 1,500 delegates from 18 countries to Melbourne in February, with the Federal Government committing another $450,000 to support the event over the next three years. The visible momentum is real, and the cohort of companies I spent two days meeting reflected it. Most were past proof-of-concept by a meaningful margin, with […]

Read more